Tango Therapeutics, Inc. (TNGX) Misses Q1 EPS by 4c

Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q1 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $6.47 million versus the consensus estimate of $7.82 million.

For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Rank One Computing (ROC) Reiterated at Buy by Benchmark Post ZTC Acquisition
• BofA expects mid to outperform small stocks in the H2